Research Article

Clinical Correlations of Novel Autoantibodies in Patients with Dry Eye

Table 2

Demographic and clinical characteristics of patients according to autoimmune disease status.

Primary SS ()Secondary SS ()Other autoimmune disease ()No known autoimmune disease () value

Demographics
 Age (years), mean (SD)58 (8.4)61 (15.5)58 (15.3)60 (10.9)0.82
 Female, n (%)11 (100%)7 (100%)18 (86%)79 (81%)0.26
SS-related symptoms, n (%)
 Dry mouth3 (27%)2 (29%)8 (38%)30 (31%)0.91
 Joint/muscle pain2 (18%)02 (9%)20 (21%)0.38
 Fatigue2 (18%)1 (14%)1 (5%)13 (13%)0.67
Diagnostic parameters, n (%)
 Anti-SSA9 (82%)4 (57%)00
 Anti-SSB3 (27%)2 (29%)00
 RF5 (46%)4 (57%)3 (14%)2 (2%)
6 (55%)3 (42%)3 (14%)2 (2%)
 Positive biopsy2/3 (67%)0/1 (0%)0/2 (0%)0/7 (0%)
Novel autoantibodies, n (%)8 (73%)1 (14%)10 (48%)37 (38%)0.06
 Anti-SP13 (27%)1 (14%)2 (9%)13 (13%)0.57
 Anti-CA63 (27%)05 (24%)21 (22%)0.53
 Anti-PSP6 (54%)04 (19%)10 (10%)0.001
Dry eye measures, mean (SD)
 Tear osmolarity (mOsm/L)323 (33.7)308 (17.4)307 (17.7)307 (14.5)0.054
 Schirmer test (mm)9.0 (8.1)4.8 (3.6)7.7 (11.5)7.9 (6.7)0.79
 Schirmer  mm, n (%)5 (71%)2 (67%)7 (78%)25 (43%)0.14
 Total OSS (0-12)8.3 (3.3)8.6 (1.8)7.2 (2.7)5.5 (3.5)0.003
  Corneal staining (0-6)3.3 (1.8)3.4 (1.5)2.9 (1.9)2.3 (1.8)0.15
  Conjunctival staining (0-6)5.0 (1.8)5.1 (1.2)4.4 (1.6)3.2 (2.3)0.002
, n (%)6 (60%)4 (67%)13 (68%)60 (72%)0.97
 mm or , n (%)8 (73%)5 (83%)17 (85%)70 (75%)0.77

Results are represented as mean (standard deviation) for continuous variables and number (percentage) for binary variables. The one-way analysis of variance (ANOVA) was used for comparison of continuous variables and chi-squared testing for categorical variables between groups. SS: Sjögren’s syndrome; SD: standard deviation; SSA: Sjögren’s syndrome-related antigen A; SSB: Sjögren’s syndrome-related antigen B; RF: rheumatoid factor; ANA: antinuclear antibody; SP1: salivary protein 1; CA6: carbonic anhydrase 6; PSP: parotid secretory antigen; OSS: ocular staining score.